Researchers from the University of Pittsburgh have discovered new ways to grow human beta cells in the laboratory. The researchers were able to induce the cells to divide and, notably, to stop the cells from dividing as well.
The cell division was achieved by adding the genes ‘cdk’ and ‘cyclin d’ into the beta cells. The way the genes were introduced into the beta cells was via a virus which was able to penetrate into the cells and deliver the genes.
Beta cells are usually very slow to divide within the body which is one reason why type 1 diabetes is able to develop very quickly. Type 1 diabetes begins when the body’s immune system attacks its own insulin producing beta cells. Within a period of weeks, someone with type 1 diabeteswill have lost sufficient beta cells to require insulin injections to keep blood sugar levels even.
Previously, beta cells have only been available from human or animal donors. This has meant that beta cells have been in short supply even for research purposes. Production of beta cells from the new method described could open doors for more research into beta cells to be possible. The research led by Professor Andrew Stewart was funded by the JDRF.
Search This Blog
-----------------------------------------------------------------------------------------------------------------------------------------------------------------
Bold new avenue for type 1 diabetes research
Michael
7:55 AM
blood sugar, diabetes, diabetic, Insulin, Medical Review, Medical Studies, type-1
2 comments
Related Posts:
Building Muscle Without Heavy WeightsWeight training at a lower intensity but with more repetitions may be as effective for building muscle as lifting heavy weights says a new opinion pie… Read More
TSA destroys Teen’s Insulin Pump Savannah Barry, a 16-year-old diabetic, is criticizing the TSA after an agent incorrectly instructed her to walk through a … Read More
Beta cell stress may trigger development of type 1 diabetesScientists have found that a specific type of cellular stress takes place in pancreatic betacells before the onset of type 1 diabetes. In type 1 diabe… Read More
Doubts Over Long Term Impact Of Group Education For Diabetes PatientsA study published in BMJ (British Medical Journal) states that there are no long term benefits from type 2 diabetes group education programs that only… Read More
Two Takeda Diabetes Drug Applications, FDA Asks For More InfoTakeda says it has received a complete response letter from the FDA regarding NDAs (new drug applications) for alogliptin and fixed-dose combination a… Read More
Have a Super Friday!
ReplyDeleteSame to you Bob. Have a great weekend, and be safe!
ReplyDelete